Navigation Links
National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
Date:8/19/2007

MOUNTAINSIDE, N.J., Aug. 14 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (OTC: NHGI.PK), today announced that Michael Cohen, CEO of the Company, and Jacob Cohen, have discovered biomaterial derived from non- embryonic stem cells, which appears to promote tissue repair in various wound care applications.

On July 26, 2007, the Company announced that while using its proprietary embryonic stem cell lines, Michael and Jacob Cohen discovered a group of biomaterials that in preclinical studies appear to increase the rate at which the tissue surrounding a wound heals, and ultimately, the strength of such newly formed tissue. Today, the Company reports that Michael and Jacob Cohen have also been able to derive such tissue repair promoting biomaterials from non-embryonic stem cells, such as umbilical cord blood cells.

The Company has filed provisional patent applications with the United States Patent and Trademark Office, which cover both the July 26, 2007 discovery and the discovery announced today.

According to Michael Cohen "By deriving these novel biomaterials from non- embryonic stem cells, such as umbilical cord blood, we believe we can avoid the costly and time consuming procedures that plague therapies developed from embryonic stem cells. This new discovery gives us the ability to cultivate tissue repair and wound healing products and commence clinical trials of such products in an expedited manner."

National Stem Cell Holding, Inc. is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. The Company is developing a pipeline of proprietary stem cell therapeutics, with a particular focus on finding a cure for diabetes. In addition to its work with stem cell therapeutics, the Company is working to leverage the commercial infrastructure and product development capabilities of its wholly-owned subsidiary, The Sperm Bank of NY. The Company's investigational products a
'/>"/>

SOURCE National Stem Cell Holding, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... (Prime), a thought leader in pharmacy benefit management, has ... 2011 Transparency in Pharmaceutical Purchasing Standards(SM) (TIPPS) certification from ... year that Prime has received this certification. ... (PBMs) that have agreed to provide pharmacy cost information ...
... Oct. 19 Ingenuity® Systems, the leading provider ... TransMed Systems, a translational medicine software and services ... and XB Bio-Integration Suite (XB-BIS).  Researchers can now ... managed and statistically analyzed by XB-BIS, directly into ...
Cached Medicine Technology:Prime Therapeutics Receives 2011 TIPPS Certification 2Ingenuity Systems and TransMed Systems Integrate Software to Support Personalized Medicine Research 2
(Date:4/17/2014)... non-cancerous prostate tissue may have nearly twice the risk ... inflammation, according to results of a new study led ... , The link between persistent inflammation and cancer was ... those with a Gleason score between 7 and ... and rapidly growing prostate cancers. , "What we,ve shown ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... in the April issue of Immunity , Kevin ... Medical Research, says it,s time to take a fresh ... sepsis, which kills millions worldwide every year, including ... released into the bloodstream to fight an injury or ... for maintaining good health without inflammation, wounds and ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
... EAST LANSING, Mich. - With the help of a ... Michigan State University is creating a cross-discipline, mentored program ... in women,s health., MSU,s new Building Interdisciplinary Research Careers ... Department of Medicine in the College of Human Medicine, ...
... MD, MPH, an endocrinologist at Nationwide Children,s Hospital, has ... customized text messages to remind adolescent diabetes patients about ... study, Dr. Dyer found an increase in overall treatment ... Dyer began developing this pilot study after realizing the ...
... , THURSDAY, July 29 (HealthDay News) -- Although millions ... ward off osteoporosis, New Zealand researchers say the supplements have ... increase in the risk for heart attack among older people. ... suggest that people get their required calcium, if possible, from ...
... is a protein that is expressed in and on ... and antigen presenting cells. This protein is known for ... response. Additionally, Professor Shachar,s lab has previously shown that ... the immune system, and that its stimulation by its ...
... influencing both morbidity and recovery after surgery. The ... intervention, which may prevent later complications. A traditional ... to identify significant weight loss over time, significantly ... nutritional factor levels and functional measurements of muscle ...
... most common cancers worldwide, particularly in China. However, ... to treat. It is important to screen for ... possess anti-cancer properties. These dietary compounds may modify ... proliferation and apoptosis. Galangin could inhibit the methoxyresorufin ...
Cached Medicine News:Health News:MSU targets women's health research with $2.5 million grant 2Health News:Pilot study supports adolescent diabetes patients through personalized text messages 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 2Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 3Health News:Calcium Supplements Linked to Boost in Heart Attack Risk 4Health News:How to detect malnutrition in patients effectively? 2
This is a reduced form of the 100 Hue test and L'Anthony New Color Test. The 40 Hue test is obviously quicker to administer. It provides extensive chromatic sensitivity and gives a quantitative score...
... Farnsworth 100 Hue Test comes boxed in clear ... the potential for test disruption by holding ... Hue test from Richmond Products includes 93 color ... durable laminated score template for copying, a supply ...
... Strep A test is as easy as 1-2-3: ... results. Increase patient satisfaction with rapid information before ... your patient immediately with the appropriate therapy; no ... Use: ,The NOW® Strep A Test is a ...
Single Use Loading Units (SULU's) Knifeless for use with MULTIFIRE ENDO GIA™ 30 12 mm (Single Use Staplers with Titanium Staples)....
Medicine Products: